Medicare's $50 weight-loss deal: who actually qualifies.

"Medicare covers Ozempic now" — you have probably seen that headline. It is half true, and the wrong half is the half that matters. Starting July 1, 2026, a new temporary program called the Medicare GLP-1 Bridge lets some people on Medicare get certain weight-loss drugs for $50 a month. But it is narrow, it is gated, and it runs out December 31, 2027. Here is the honest, plain-English version — who actually qualifies, why a diabetes diagnosis can push you off the program, which drugs are covered, and the $50 catch. Every figure traces back to CMS and Medicare.gov.

Why the "Medicare covers Ozempic now" headline is only half true

For years, regular Medicare drug plans were barred by law from covering a drug used only for weight loss. The Bridge does not repeal that. It does not fold these drugs into your normal Part D plan. It sits outside your plan entirely — a separate, temporary lane the government built to test what happens when access is widened, and to collect data before deciding anything permanent. So the accurate version of the headline is narrower: for a limited time, a specific group of people can get a short list of weight-loss drugs, through a special side door, for $50. That is the truth, and the truth is what keeps you from being disappointed at the pharmacy counter.

What the GLP-1 Bridge actually is: temporary, weight-only, gated

Here is the mental model to hang the whole thing on. The Medicare GLP-1 Bridge is a short-term test program — the government's own word for it is a demonstration. It lets eligible people with Medicare drug coverage get certain GLP-1 medications, for weight loss, at a flat $50 a month. Three words to hold onto: temporary, weight-only, and gated.

• Temporary. It runs from July 1, 2026, and is scheduled to end December 31, 2027 — a little over a year and a half, and then, unless something changes, it is gone.
• Weight-only. It is strictly for weight loss and weight maintenance — not for diabetes, not for anything else.
• Gated. There is a real list of conditions you have to clear to get in.

It sits outside your Part D plan (and why that matters)

This one structural fact drives almost every surprise in this program. The Bridge does not run through your Part D plan — a single central processor handles the prior authorization, claims, and pharmacy payment, and your Part D plan carries no risk and does not even have to opt in. That is convenient in one way, but it means the $50 you pay lives in a completely separate bucket from the rest of your drug spending. Keep that in mind; it comes back at the end and it is the most misunderstood part of the whole deal.

First gate: you need Medicare Part D drug coverage

Meet Nancy. She is 68, she saw the headline, and she is thrilled — so she picks up the phone to sign herself up, treating it like flipping a switch. The person on the other end asks one question she was not ready for: which Medicare drug plan are you on? Nancy is on Original Medicare, Part A and Part B, and she never added a separate drug plan. And right there she learns the very first rule the hard way: the Bridge only works if you already have Medicare drug coverage — Part D. No drug plan, no Bridge, no matter how well you would meet every other rule.

What counts as "drug coverage" is broader than people think. Any of these gets that first question a yes: a standalone Part D prescription drug plan; a Medicare Advantage plan that includes drug coverage (an MA-PD, HMO or PPO); a Special Needs Plan (SNP); an employer or union group plan that runs through Medicare (an EGWP); or the limited LI NET program. What does not count: Part A and Part B alone, with no drug plan attached. That was Nancy — and if you are not sure which bucket you are in, that is the very first thing to pin down.

The BMI gate: the lower the weight, the more the health has to justify it

Meet Gary, 62. His BMI is about 33, and he has prediabetes. He had heard the "magic number" was 35, so he does the math, lands at 33, and writes himself off — not me, I'm under the line. He is about to leave $50 medicine on the table over a number he half-remembered, because there is not one door on weight. There are three, and here is the principle that makes them click: the lower your weight, the more your health has to justify the medicine.

• BMI 35 or higher — qualifies on weight alone.
• BMI 30 to 34.99 — qualifies plus at least one listed condition: HFpEF (a specific kind of heart failure), uncontrolled high blood pressure, chronic kidney disease at stage 3a or worse, prediabetes, a prior heart attack or stroke, or symptomatic peripheral artery disease. This is Gary's door: prediabetes is right there on the list. He is not out — he is in.
• BMI 27 to 29.99 — the door still opens, but the list of conditions that count gets shorter: prediabetes, a prior heart attack or stroke, or symptomatic peripheral artery disease.

One rule holds at every level, and your doctor has to confirm it: that you are using the medication as part of a real diet-and-exercise plan. The drug is meant to be part of the plan, not the whole plan.

Which drugs are covered (and the one with a catch)

When your doctor writes the prescription, it can come from a short, specific list:

• Foundayo — the tablet form.
• Wegovy — covered as either an injection or a tablet.
• Zepbound — but only in one specific form: the KwikPen. Not the single-dose vials, not the single-dose pens. If you and your doctor lean toward Zepbound, the word that has to land on that prescription is KwikPen, or the coverage does not follow the pen.

Notice that Ozempic is not on this list — which is exactly why the "Medicare covers Ozempic now" headline is so misleading.

Is $50 still a good deal? Usually — if you budget it right

Do not hear "catch" and walk away thinking the whole thing is a trap. For a lot of people — Gary, for instance — the Bridge is straightforwardly a great deal. If Gary was going to pay many hundreds a month out of pocket, or simply go without, then $50 a month is a real gift, and the fact that it does not touch his Part D cap is almost beside the point, because that drug was never going to be covered by his Part D plan anyway. The neighbor who needs to slow down is Walter — the one mentally filing the $50 under his regular drug spending. It is not "good deal versus bad deal." It is: know exactly which bucket the $50 lives in, and plan the rest of your year around the truth.

The deadline nobody's shouting about

Here is the line that gets buried at the bottom of every article, and it may be the most important one: this program has an expiration date. It runs from July 1, 2026, and is currently scheduled to end December 31, 2027 — a little over a year and a half. It is a test; the government is gathering data before deciding whether to build anything permanent. So if you are a genuine fit, the calendar itself is part of the decision. The reassuring half: once your doctor completes the approval — the prior authorization — that approval is good all the way through December 31, 2027, refills and dose changes included, as long as you do not switch to a different GLP-1. The window to start is finite; the coverage, once you are in, is steady.

How to get it: the path, start to finish

Back to Nancy, once she has sorted out her coverage question. Her path is the whole thing on one screen:

• Confirm you actually have Part D drug coverage — the exact thing that tripped Nancy up.
• Check your eligibility at the official page, Medicare.gov/glp1bridge, or by calling 1-800-MEDICARE (1-800-633-4227). Use the government's own page, not a third-party site selling something around the edges.
• Talk to your provider. If you are eligible, they send the prescription for a covered GLP-1 to your pharmacy and complete the prior authorization when it is requested.
• At the pharmacy, have your Medicare Number or the last four digits of your Social Security number ready — that is normal, not a red flag.
• Watch for the confirmation letter under the Medicare GLP-1 Bridge, and keep it. That letter is your proof you are in.

Four neighbors, four different right answers

Line the four up one last time, because they are the whole point:

• Nancy — excited, but no drug plan. Her real first move is not the Bridge; it is understanding her Part D enrollment. Without that first door, nothing else matters.
• Gary — meets the BMI gate, no disqualifying diagnosis, a doctor willing to build a real plan. He may be exactly who this was designed for. Worth a serious conversation this month, while the window is open.
• Sharon — carrying a diagnosis like type 2 diabetes, sleep apnea, or fatty liver disease. She should not assume the Bridge; she should ask whether her own Part D plan already opens a door.
• Walter — thrilled about the $50. He should get it in writing which bucket it lives in and plan the rest of his year's drug spending around the fact that it stands alone.

Not one of those answers is the headline's "everybody gets Ozempic for fifty bucks." The job was never to find the answer — it was to find your answer.

Related

Go deeper on Medicare: Medicare enrollment at 65: windows & penalties, IRMAA, the Medicare income surcharge, and the July 2026 money changes for retirees.

Sources

• CMS: CMS Launches Medicare GLP-1 Bridge, Expanding Access to GLP-1 Medications (press release)
• CMS: Medicare GLP-1 Bridge program & FAQ hub
• Medicare: Weight loss drugs / GLP-1 Bridge (who qualifies)
• Medicare: GLP-1 Bridge fact sheet (PDF)
• Check your eligibility: Medicare.gov/glp1bridge · 1-800-MEDICARE (1-800-633-4227)

Not financial or medical advice. This article is educational only — it is not personal financial advice, and it is not medical, tax, or legal advice. Jeffrey is not a doctor. Whether a GLP-1 is right for you is a conversation for you and your physician, and you should check your own eligibility at Medicare.gov/glp1bridge before acting on anything here.